Heterocyclic derivatives for the treatment of cancer and other proliferative diseases
申请人:——
公开号:US20020143182A1
公开(公告)日:2002-10-03
The invention relates to certain heterocyclic compounds useful for the treatment of cancer and other diseases, having the Formula (I):
1
wherein:
(a) m is an integer 0 or 1;
(b) R
12
is an alkyl, a substituted alkyl, a cycloalkyl, a substituted cycloalkyl, a heterocyclic, a substituted heterocyclic, a heteroaryl, a substituted heteroaryl, an aryl or a substituted aryl residue;
(c) Ar
3
is an aryl, a substituted aryl, a heteroaryl or a substituted heteroaryl residue;
(d) Ar
4
is an aryl, a substituted aryl, a heteroaryl or a substituted heteroaryl residue;
(e) R
5
is hydrogen, hydroxy, alkyl or substituted alkyl;
(f) - - - - - represents a bond present or absent; and
(g) W, X, Y and Z are independently or together C(O)—, C(S), S, O, or NH; or a pharmaceutically acceptable salt thereof.
本发明涉及一些杂环化合物,其具有公式(I),可用于治疗癌症和其他疾病,其中:1
(a)m是整数0或1;
(b)R12是烷基,取代烷基,环烷基,取代环烷基,杂环基,取代杂环基,杂环芳基,取代杂环芳基,芳基或取代芳基残基;
(c)Ar3是芳基,取代芳基,杂环芳基或取代杂环芳基残基;
(d)Ar4是芳基,取代芳基,杂环芳基或取代杂环芳基残基;
(e)R5是氢,羟基,烷基或取代烷基;
(f)- - - - -代表存在或不存在的键;和
(g)W,X,Y和Z独立地或一起是C(O)—,C(S),S,O或NH;或其药学上可接受的盐。